IMO, CV writes off very little inventory compared to how much they don't sell. If there's not a big write down in the next report, I think CV is keeping raw material around longer than they are supposed to. Who's checking though right? Not the FDA. The inventory keeps those "assets" looking fluffy on the balance sheet...
Inventory Inventory as of September 30, 2022 and December 31, 2021 was comprised of the following (in thousands): September 30, 2022 December 31, 2021 Raw materials $3,698 $4,023 Work in process 1,221 1,286 Finished goods 2,307 3,315 $7,226 $8,624
The Company recorded inventory write-downs of $0.1 million and $0.3 million for the three and nine months ended September 30, 2022, respectively. Inventory write-offs for the three and nine months ended September 30, 2021 were $0.1 million and $0.2 million, respectively.